This week’s Advanced Healthcare Materials covers.
Nanotherapeutic Systems for Local Treatment of Brain Tumors
Malignant brain tumors are heterogeneous and invasive, with high morbidity and mortality rates. The main challenge associated in treating such tumors is the presence of the blood-brain barrier (BBB), which actively filters out molecules entering from the blood stream. (Image credit: Triff/Shutterstock)
Oral Nucleic Acid Therapy for Gastro-Intestinal Diseases
DNA and RNA (nucleic acids) interference therapies have the potential to treat many human diseases.
“Pent-up” Drug Delivery for Tumor Therapy with Trimodal Imaging
Controlled delivery of anti-tumor drug with a new design incorporating a phase-change material in magnetic nanoparticles allowing chemo-photothermal combined tumor therapy with multimodal tumor imaging.
“Why Are We Interested in Monocytes?”
Various views on the same cell are discussed in a recent Special Issue on Monocytes and Marcophages.
Special Issue on Quantitative Phase Imaging for Label-Free Cytometry
A Special Issue that reports on the latest technical developments in QPI used to study the mechanisms of cancer and neurodegenerative disorders, to develop multispecific pharmaceutical formulations, and as a robust segmentation technology for microbial cells.
Behavioral Tests for Autism Spectrum Disorders using a Mouse Model
Dr. Lucio Costa and co-workers describe six different behavioral tests in the three main areas affected in ASD (repetitive behavior, communication, social interactions).
Cover Art – Featuring Neural Stem Cells, Wound Healing and More
May’s Advanced Healthcare Materials covers.
Umbilical Cord Mesenchymal Stromal Cell Isolation and Characterization
New protocols for the isolation of UC-MSCs are explored, including several helpful, individual protocols to aid quality control and ensure that the UC-MSCs are characterized thoroughly while improving yield.
Enzymes Play a Role in Corneal Blindness
New research has revealed that a pair of catalytic enzymes, called extracellular signal-regulated kinases 1 and 2 (ERK1/2), may play an essential role in the development of corneal blindness. (Image credit: MJTH/Shutterstock).